What is the treatment for Tinea skin infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Tinea Skin Infections

For tinea corporis and tinea cruris, use topical antifungal therapy (terbinafine or butenafine cream) for 2 weeks as first-line treatment, reserving oral therapy for extensive disease, treatment failure, or immunocompromised patients. 1, 2

Diagnostic Confirmation Before Treatment

  • Confirm diagnosis with potassium hydroxide (KOH) preparation or fungal culture before initiating therapy, particularly for onychomycosis and tinea capitis 3
  • Collect specimens using scalpel scraping, hair pluck, brush, or swab depending on the lesion location 1
  • In clinically obvious cases with scale, lymphadenopathy, alopecia, or kerion, start empiric treatment immediately while awaiting culture results 4

Treatment by Site and Severity

Tinea Corporis and Tinea Cruris (Body and Groin)

Topical Therapy (First-Line):

  • Apply terbinafine 1% cream or butenafine cream once or twice daily for 2 weeks 2, 3
  • Continue treatment for at least 1 week after clinical clearing 2
  • Topical therapy alone is sufficient for limited disease 1, 2

Oral Therapy (When Topical Fails or Extensive Disease):

  • Terbinafine 250 mg daily for 1-2 weeks is particularly effective against T. tonsurans 1, 5
  • Itraconazole 100 mg daily for 15 days achieves 87% mycological cure rate (superior to griseofulvin's 57%) 1
  • Fluconazole 50-100 mg daily or 150 mg once weekly for 2-3 weeks is a third-line option 1, 5

Tinea Capitis (Scalp)

Oral therapy is absolutely required; topical treatment alone is never effective 4

Treatment Selection Based on Organism:

  • For Trichophyton species: Terbinafine is superior and preferred 4

    • <20 kg: 62.5 mg daily for 2-4 weeks
    • 20-40 kg: 125 mg daily for 2-4 weeks
    • 40 kg: 250 mg daily for 2-4 weeks 4

  • For Microsporum species: Griseofulvin is more effective and preferred 4

    • <50 kg: 15-20 mg/kg/day for 6-8 weeks
    • 50 kg: 1 g/day for 6-8 weeks 4, 6

    • Take with fatty food to increase absorption 7
  • Itraconazole (second-line): Active against both organisms 4

    • 50-100 mg daily for 4 weeks or 5 mg/kg/day for 2-4 weeks 4

Tinea Pedis (Feet)

Topical Therapy:

  • Terbinafine 1% cream once or twice daily for 1-2 weeks achieves >80% cure rates 8
  • Allylamine medications require only 1-2 weeks of treatment 2
  • Traditional azole therapy requires 4 weeks 2

Oral Therapy (for extensive or moccasin-type):

  • Terbinafine 250 mg daily for 2 weeks 5, 3
  • Itraconazole 100 mg daily for 2 weeks or 400 mg daily for 1 week 5
  • Fluconazole 150 mg once weekly (pulse dosing) 5

Tinea Unguium (Onychomycosis)

Oral terbinafine is first-line therapy due to high cure rate, tolerability, and low cost 3

  • Fingernails: minimum 4 months 6
  • Toenails: minimum 6 months 6

Treatment Failure Management

If mycology remains positive but clinical improvement is seen:

  • Continue current therapy for an additional 2-4 weeks 4

If no clinical improvement:

  • Assess for non-compliance, suboptimal drug absorption, organism resistance, or reinfection 4
  • Switch agents: from terbinafine to griseofulvin for Microsporum, or to itraconazole 4

Essential Adjunctive Measures

  • Screen all family members and close contacts for T. tonsurans infections, as >50% may be affected 1, 4
  • Treat asymptomatic carriers with high spore loads systemically 4
  • Clean all fomites (hairbrushes, combs, towels) with disinfectant or 2% sodium hypochlorite solution 1, 4
  • Use antifungal shampoos (ketoconazole 2%, selenium sulfide 1%, or povidone-iodine) to reduce spore transmission 7
  • Avoid skin-to-skin contact with infected individuals and do not share personal items 1

Treatment Endpoint and Monitoring

The definitive endpoint is mycological cure, not clinical cure 1, 4

  • Repeat mycology sampling until clearance is documented 1, 4
  • Clinical improvement alone is insufficient to stop therapy 4
  • Follow-up should include both clinical and mycological assessment 1

Critical Pitfalls to Avoid

  • Never use topical antifungals alone for tinea capitis—they do not penetrate hair follicles 4
  • Do not use terbinafine for Microsporum infections—griseofulvin is superior 4
  • Do not stop treatment based on clinical appearance alone—confirm mycological cure 1, 4
  • Do not forget to screen household contacts, especially with T. tonsurans 1, 4
  • Avoid using combination antifungal/steroid agents long-term due to risk of skin atrophy 2

References

Guideline

Treatment of Tinea Corporis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Topical treatment of common superficial tinea infections.

American family physician, 2002

Research

Diagnosis and management of tinea infections.

American family physician, 2014

Guideline

Treatment of Tinea Capitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Oral therapy of common superficial fungal infections of the skin.

Journal of the American Academy of Dermatology, 1999

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Tinea pedis: clinical experience and efficacy of short treatment.

Dermatology (Basel, Switzerland), 1997

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.